USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cadila Healthcare Ltd.

USPTO PatentsView assignee record - 79 granted patents across 18 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07D (HETEROCYCLIC COMPOUNDS).

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

14.3

Avg claims per patent

-82%

5-year filing velocity

The verdict

Cadila holds 79 US patents across 18 technology areas, rank #4,458 of 50,000 tracked assignees.

#4,458
of 50,000 US assignees by volume: Top 35%
by Innovation Score (40.6/100): 14.3
avg claims per patent: -82%
filing velocity, last 5 yrs

Portfolio overview

Cadila Healthcare Ltd. has been granted 79 US utility patents between 2015 and 2022, placing Cadila Healthcare Ltd. at rank #4,458 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.3 claims per patent with primary concentration in C07D (HETEROCYCLIC COMPOUNDS). As a Foreign Corporation, Cadila Healthcare Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Cadila sits between Biocatch Ltd. (79 patents, rank #4,454) and ECA Medical Instruments (79 patents, rank #4,462) - the closest US assignees by grant volume. The composite Innovation Score of 40.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 12 grants, compared with 67 in the 2015–2019 window, a -82% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cadila Healthcare Ltd.'s 14.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cadila Healthcare Ltd. against peers pursuing similar technology classes.

Biocatch

79
Bioventures

79
Checkpoint Systems

79
CSEM Centre Suiss…

79
Corning Precision…

79
Createme

79
Early Morning

79
ECA Medical Instr…

79
Cadila Healthcare ◀

79

What this shows Cadila holds 79 patents at rank #4,458, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cadila

By rank, the assignees closest to #4,458 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Cadila's primary technology class.

Cadila's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cadila Healthcare Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	15	19.0%
2016	15	19.0%
2017	21	26.6%
2018	10	12.7%
2019	6	7.6%
2020	3	3.8%
2021	5	6.3%
2022	4	5.1%

Which technologies does Cadila Healthcare Ltd. patent most?

C07D - HETEROCYCLIC COMPOUNDS 46

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 45

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 44

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 10

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 9

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 8

C07K - PEPTIDES 7

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 7

B65B - MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 4

C30B - SINGLE-CRYSTAL GROWTH ; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL ; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE ; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WI 4

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 4

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 2

A61Q - SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS 2

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 2

B82Y - SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES 1

Top 15 of 18 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#4,458

Across all tracked assignees

Innovation Score

40.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cadila Healthcare Ltd. hold?

Cadila Healthcare Ltd. holds 79 US granted patents filed between 2015 and 2022, spanning 18 technology areas.

What is Cadila Healthcare Ltd.'s Innovation Score?

Cadila Healthcare Ltd. has an Innovation Score of 40.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cadila Healthcare Ltd. focus on?

Cadila Healthcare Ltd.'s top technology area is C07D (HETEROCYCLIC COMPOUNDS) with 46 patents. The company has filed patents in 18 CPC subclasses total.

Is Cadila Healthcare Ltd.'s patent filing rate increasing or decreasing?

Cadila Healthcare Ltd.'s recent filing velocity is -82% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Cadila Healthcare Ltd.'s patents?

Cadila Healthcare Ltd.'s patents average 14.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the Cadila Healthcare Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Cadila's 79 grants land it in the top 35% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Cadila ranks #4,458 of 50,000. Top 50 holders
Most of this portfolio concentrates in C07D - see who else leads that technology area. C07D leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.